Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

1.650 +0.070 (+4.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,350,490
Open 1.610
Bid (Size) 1.590 (20)
Ask (Size) 1.650 (10)
Prev. Close 1.580
Today's Range 1.580 - 1.660
52wk Range 1.260 - 10.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire

Performance

YTD
N/A
N/A
1 Month
-40.4%
-40.4%
3 Month
-57.3%
-57.3%
6 Month
-61.0%
-61.0%
1 Year
-80.4%
-80.4%

More News

Read More
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
ROSEN, A LEADING AND RANKED FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
From Faruqi & Faruqi LLP
Via GlobeNewswire
SANA Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP for Information on How to Lead the Class Action Against Sana Biotechnology, Inc.
From Robbins LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
From The Rosen Law Firm PA
Via GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
From Faruqi & Faruqi LLP
Via GlobeNewswire
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1
Via Stocktwits
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
From Faruqi & Faruqi LLP
Via GlobeNewswire
Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action Lawsuit Against SANA
From Robbins LLP
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference
From Sana Biotechnology, Inc
Via GlobeNewswire
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why
Via Stocktwits

Frequently Asked Questions

Is Sana Biotechnology, Inc. - Common Stock publicly traded?
Yes, Sana Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Sana Biotechnology, Inc. - Common Stock trade on?
Sana Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sana Biotechnology, Inc. - Common Stock?
The ticker symbol for Sana Biotechnology, Inc. - Common Stock is SANA on the Nasdaq Stock Market
What is the current price of Sana Biotechnology, Inc. - Common Stock?
The current price of Sana Biotechnology, Inc. - Common Stock is 1.650
When was Sana Biotechnology, Inc. - Common Stock last traded?
The last trade of Sana Biotechnology, Inc. - Common Stock was at 04/17/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.